NEW YORK (360Dx) – Roche today announced the US Food and Drug Administration has cleared its Cobas m 511 hematology testing solution.

The analyzer combines a cell counter, slide maker and stainer, and a digital morphology analyzer into one integrated solution, enabling laboratories to report the complete blood count, white blood cell differential and reticulocyte results, as well as prepare, stain, and analyze blood smears for abnormal results thorough a single process, Roche said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the Firestone Institute for Respiratory Health at McMaster University developed a cellular and molecular phenotyping pipeline using archived samples of lung tissue derived from patients diagnosed with fibrotic interstitial lung disease.